The Latest Breaking News from BioNTech

Moderna stock toppled Friday on mixed results for its flu shot — a rival to experimental vaccines from BioNTech, CureVac and Sanofi.

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

Health care’s business class returned to San Francisco last week for JPMorgan’s annual health care confab

HONG KONG: Scores of mainland Chinese travellers are rushing to Hong Kong to receive mRNA Covid-19 vaccines, which are not available on the Chinese mainland, as the country grapples with a torrent of infections that have overwhelmed its health system.

Scores of mainland Chinese travellers are rushing to Hong Kong to receive mRNA COVID-19 vaccines, which are not available on the Chinese mainland, as the country grapples with a torrent of infections which have overwhelmed its health system.

The UK government recently announced that it is partnering with German firm BioNTech to test vaccines for cancer and other diseases. The project aims to build on the mRNA vaccine technology that BioNTech became famous for developing, and which has been so successful at preventing serious illness and death from…

Personalised cancer vaccine trials in England will roll out this year after the United Kingdom government signed a deal with a company behind one of the major COVID-19 vaccines.

Fosun Pharma opens online reservation platform for BioNTech vaccination as Covid border controls are set to end

If there's one biotech area to watch in 2023, it's genetic medicine, like CRISPR. But other trends also point to a big year for biotech stocks.